Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Rheumatoid Arthritis

Free Subscription Articles published in Clin Exp Immunol Retrieve available abstracts of 37 articles: HTML format Text format

Single Articles

October 2018
1. HU X, Tang J, Hu X, Bao P, et al
   Imatinib inhibits CSF1R that stimulates proliferation of rheumatoid arthritis fibroblast-like synoviocytes.
   Clin Exp Immunol. 2018 Oct 3. doi: 10.1111/cei.13220.
   PubMed     Text format     Abstract available
   
   
   September 2018
2. LIN J, He Y, Wang B, Xun Z, et al
   Blocking of YY1 Reduce Neutrophil Infiltration by Inhibiting IL-8 Production via PI3K-Akt-mTOR Signaling Pathway in Rheumatoid Arthritis.
   Clin Exp Immunol. 2018 Sep 19. doi: 10.1111/cei.13218.
   PubMed     Text format     Abstract available
   
   
   
3. GUO C, Fu R, Wang S, Huang Y, et al
   NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis.
   Clin Exp Immunol. 2018 Sep 16. doi: 10.1111/cei.13167.
   PubMed     Text format     Abstract available
   
   
   
4. LUO Q, Zhang L, Li X, Fu B, et al
   Identification of circular RNAs hsa_circ_0044235 in peripheral blood as novel biomarkers for Rheumatoid Arthritis.
   Clin Exp Immunol. 2018 Sep 14. doi: 10.1111/cei.13181.
   PubMed     Text format     Abstract available
   
   
   August 2018
5. KASTBOM A, Roos Ljungberg K, Ziegelasch M, Wettero J, et al
   Changes in anti-citrullinated protein antibody isotype levels in relation to disease activity and response to treatment in early rheumatoid arthritis.
   Clin Exp Immunol. 2018 Aug 23. doi: 10.1111/cei.13206.
   PubMed     Text format     Abstract available
   
   
   July 2018
6. KOMATSU N, Takayanagi H
   Immune-bone interplay in the structural damage in rheumatoid arthritis.
   Clin Exp Immunol. 2018 Jul 19. doi: 10.1111/cei.13188.
   PubMed     Text format     Abstract available
   
   
   
7. CECCARELLI F, Orru G, Pilloni A, Bartosiewicz I, et al
   Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients.
   Clin Exp Immunol. 2018 Jul 15. doi: 10.1111/cei.13184.
   PubMed     Text format     Abstract available
   
   
   June 2018
8. GANG X, Xu H, Si L, Zhu X, et al
   Treatment effect of CDKN1A on rheumatoid arthritis by mediating proliferation and invasion of fibroblast-like synoviocytes cells.
   Clin Exp Immunol. 2018 Jun 19. doi: 10.1111/cei.13161.
   PubMed     Text format     Abstract available
   
   
   
9. DUNAEVA M, Blom J, Thurlings R, Pruijn GJM, et al
   Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis.
   Clin Exp Immunol. 2018 Jun 12. doi: 10.1111/cei.13156.
   PubMed     Text format     Abstract available
   
   
   January 2018
10. ZHANG Y, Wang S, Dong H, Yi X, et al
    LAIR-1 shedding from human fibroblast-like synoviocytes in rheumatoid arthritis following TNF-alpha stimulation.
    Clin Exp Immunol. 2018 Jan 12. doi: 10.1111/cei.13100.
    PubMed     Text format     Abstract available
    
    
    
11. ALIVERNINI S, Tolusso B, Ferraccioli G, Gremese E, et al
    Driving chronicity in rheumatoid arthritis - perpetuating role of myeloid cells.
    Clin Exp Immunol. 2018 Jan 8. doi: 10.1111/cei.13098.
    PubMed     Text format     Abstract available
    
    
    December 2017
12. FERRACCIOLI G, Gremese E
    B cell activating factor (BAFF) and BAFF receptors: fakes and facts.
    Clin Exp Immunol. 2017;190:291-292.
    PubMed     Text format     Abstract available
    
    
    November 2017
13. XU L, Hu F, Zhu H, Liu X, et al
    Soluble TAM receptor tyrosine kinases in rheumatoid arthritis: Correlation with disease activity and bone destruction.
    Clin Exp Immunol. 2017 Nov 17. doi: 10.1111/cei.13082.
    PubMed     Text format     Abstract available
    
    
    
14. LI J, Xu B, Wu C, Yan X, et al
    TXNDC5 Contributes to Rheumatoid Arthritis by Down-regulating IGFBP1 Expression.
    Clin Exp Immunol. 2017 Nov 13. doi: 10.1111/cei.13080.
    PubMed     Text format     Abstract available
    
    
    October 2017
15. EBE H, Matsumoto I, Kawaguchi H, Kurata I, et al
    Clinical and functional significance of STEAP4-splice variant in CD14+ monocytes in patients with rheumatoid arthritis.
    Clin Exp Immunol. 2017 Oct 28. doi: 10.1111/cei.13076.
    PubMed     Text format     Abstract available
    
    
    
16. TAKAHASHI H, Tsuboi H, Asashima H, Hirota T, et al
    cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjogren's syndrome.
    Clin Exp Immunol. 2017;190:96-109.
    PubMed     Text format     Abstract available
    
    
    
17. ZHANG S, Huang G, Yuan K, Zhu Q, et al
    Tanshinone IIA ameliorates chronic arthritis in mice by modulating neutrophil activities.
    Clin Exp Immunol. 2017;190:29-39.
    PubMed     Text format     Abstract available
    
    
    September 2017
18. RODRIGUEZ PC, Prada DM, Moreno E, Aira LE, et al
    The anti-CD6 antibody itolizumab provides clinical benefit without lymphopenia in rheumatoid arthritis patients: results from a 6-month, open-label phase I clinical trial.
    Clin Exp Immunol. 2017 Sep 30. doi: 10.1111/cei.13061.
    PubMed     Text format     Abstract available
    
    
    August 2017
19. TANG Y, Wang B, Sun X, Li H, et al
    Rheumatoid arthritis fibroblast-like synoviocytes cocultured with PBMC increased peripheral CD4+CXCR5+ICOS+ T cells numbers.
    Clin Exp Immunol. 2017 Aug 18. doi: 10.1111/cei.13025.
    PubMed     Text format     Abstract available
    
    
    
20. BECERRA E, De La Torre I, Leandro MJ, Cambridge G, et al
    B cell phenotypes in patients with rheumatoid arthritis relapsing after Rituximab: Expression of B cell activating factor-binding receptors on B cell subsets.
    Clin Exp Immunol. 2017 Aug 11. doi: 10.1111/cei.13024.
    PubMed     Text format     Abstract available
    
    
    July 2017
21. WEHMEYER C, Pap T, Buckley CD, Naylor AJ, et al
    The role of stromal cells in inflammatory bone loss.
    Clin Exp Immunol. 2017;189:1-11.
    PubMed     Text format     Abstract available
    
    
    
22. MAMELI G, Erre GL, Caggiu E, Mura S, et al
    Identification of a HERV-K env surface peptide highly recognized in Rheumatoid Arthritis (RA) patients: a cross-sectional case-control study.
    Clin Exp Immunol. 2017;189:127-131.
    PubMed     Text format     Abstract available
    
    
    June 2017
23. BOMMARITO D, Hall C, Taams LS, Corrigall VM, et al
    Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.
    Clin Exp Immunol. 2017;188:455-466.
    PubMed     Text format     Abstract available
    
    
    
24. SCHAPER F, de Leeuw K, Horst G, Maas F, et al
    Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
    Clin Exp Immunol. 2017;188:412-419.
    PubMed     Text format     Abstract available
    
    
    May 2017
25. STUMER J, Biermann MHC, Knopf J, Magorivska I, et al
    Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
    Clin Exp Immunol. 2017 May 16. doi: 10.1111/cei.12987.
    PubMed     Text format     Abstract available
    
    
    
26. WILLIS VC, Banda NK, Cordova KN, Chandra PE, et al
    Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis.
    Clin Exp Immunol. 2017;188:263-274.
    PubMed     Text format     Abstract available
    
    
    
27. AGGARWAL A, Gupta R, Negi VS, Rajasekhar L, et al
    Urinary haptoglobin, alpha-1 anti-chymotrypsin and retinol binding protein identified by proteomics as potential biomarkers for lupus nephritis.
    Clin Exp Immunol. 2017;188:254-262.
    PubMed     Text format     Abstract available
    
    
    April 2017
28. MITCHELL TS, Moots RJ, Wright HL
    JAK inhibitors prevent migration of rheumatoid arthritis neutrophils towards interleukin-8, but do not inhibit priming of the respiratory burst or ROS production.
    Clin Exp Immunol. 2017 Apr 2. doi: 10.1111/cei.12970.
    PubMed     Text format     Abstract available
    
    
    
29. SCHINNERLING K, Aguillon JC, Catalan D, Soto L, et al
    The role of IL-6 signaling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
    Clin Exp Immunol. 2017 Apr 1. doi: 10.1111/cei.12966.
    PubMed     Text format     Abstract available
    
    
    
30. CONTRERAS RUIZ L, Mir FA, Turpie B, Masli S, et al
    Thrombospondin-derived peptide attenuates Sjogren's syndrome-associated ocular surface inflammation in mice.
    Clin Exp Immunol. 2017;188:86-95.
    PubMed     Text format     Abstract available
    
    
    February 2017
31. TAHARA M, Tsuboi H, Segawa S, Asashima H, et al
    RORgammat antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjogren's syndrome-like sialadenitis.
    Clin Exp Immunol. 2017;187:213-224.
    PubMed     Text format     Abstract available
    
    
    December 2016
32. APOSTOLOU E, Kapsogeorgou EK, Konsta OD, Giotakis I, et al
    Expression of type III interferons (IFNlambdas) and their receptor in Sjogren's syndrome.
    Clin Exp Immunol. 2016;186:304-312.
    PubMed     Text format     Abstract available
    
    
    October 2016
33. RUSCITTI P, Cipriani P, Ciccia F, Di Benedetto P, et al
    H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease.
    Clin Exp Immunol. 2016;186:30-8.
    PubMed     Text format     Abstract available
    
    
    
34. PAN ZJ, Horton CG, Lawrence C, Farris AD, et al
    Plasmacytoid dendritic cells and type 1 interferon promote peripheral expansion of forkhead box protein 3(+) regulatory T cells specific for the ubiquitous RNA-binding nuclear antigen La/Sjogren's syndrome (SS)-B.
    Clin Exp Immunol. 2016;186:18-29.
    PubMed     Text format     Abstract available
    
    
    August 2016
35. CICCIA F, Guggino G, Ferrante A, Cipriani P, et al
    Interleukin-9 and T helper type 9 cells in rheumatic diseases.
    Clin Exp Immunol. 2016;185:125-32.
    PubMed     Text format     Abstract available
    
    
    July 2016
36. SZITTNER Z, Bentlage AE, Rovero P, Migliorini P, et al
    Label-free detection of immune complexes with myeloid cells.
    Clin Exp Immunol. 2016;185:72-80.
    PubMed     Text format     Abstract available
    
    
    June 2016
37. ALUNNO A, Carubbi F, Bistoni O, Caterbi S, et al
    Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjogren's syndrome: a pilot study.
    Clin Exp Immunol. 2016;184:284-92.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Rheumatoid Arthritis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: